Nonetheless, P53 is highly mutated in gynecological cancers ( > 90% in ovaries and 25-85% in the endometrium) being an important factor for tumorigenesis and cancer initiation (Figure 2C) [92, 152, 154]. This evidence concerns the gene TP53 and female reproductive organ cancer.